Cary Street Partners Investment Advisory’s Zomedica Corp. ZOM Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,300	Closed	-$1.41K	–	810
2024 Q3	$1.41K	Hold	10,300	–	–	﹤0.01%	760
2024 Q2	$1.51K	Hold	10,300	–	–	﹤0.01%	747
2024 Q1	$1.5K	Hold	10,300	–	–	﹤0.01%	696
2023 Q4	$2.06K	Hold	10,300	–	–	﹤0.01%	648
2023 Q3	$1.72K	Hold	10,300	–	–	﹤0.01%	1681
2023 Q2	$2.06K	Hold	10,300	–	–	﹤0.01%	1583
2023 Q1	$2.18K	Hold	10,300	–	–	﹤0.01%	1489
2022 Q4	$1.68K	Hold	10,300	–	–	﹤0.01%	1526
2022 Q3	$2K	Buy	+10,300	New	+$2.73K	﹤0.01%	503

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cary Street Partners Investment Advisory's ZOM Position: Q4 2024 in Review

Cary Street Partners Investment Advisory sold out of Zomedica Corp. (ZOM) in Q4 2024, closing a stake of 10,300 shares — an estimated $1.41K sold.

Cary Street Partners Investment Advisory first reported a position in ZOM in Q3 2022 and held it in 9 quarters. The position peaked at $2.18K in Q1 2023. 93 funds tracked by Wall St. Rank hold ZOM as of Q4 2024.

Cary Street Partners Investment Advisory reported no remaining Zomedica Corp. position as of Q4 2024 after selling out during the quarter.
Cary Street Partners Investment Advisory sold 10,300 Zomedica Corp. shares in Q4 2024, an estimated $1.41K.
Cary Street Partners Investment Advisory first reported a position in Zomedica Corp. in Q3 2022 and held it in 9 quarters.
Cary Street Partners Investment Advisory's Zomedica Corp. position peaked at $2.18K in Q1 2023.
93 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2024.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2024, filed 14 Feb 2025.